To demonstrate this, we returned to the same sample set from the previous study and applied immunoenrichment coupled to mass spectrometry to capture and quantify albumin-bound proteins at baseline and 3–12 month follow up after stroke–related PFO, with and without endovascular closure [4]. Here, ALB is linked to Patent foramen ovale.